Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome?

Figure 3 Final diagnosis for symptomatic patients with nodular lymphoid hyperplasia. Patients with nodular lymphoid hyperplasia (s-NLH) patients were divided into organic and functional bowel disorders; the latter subset was further stratified into IBS with prevalent diarrhoea (IBS-D), or constipation (IBS-C), or mixed bowel habit (IBS-M), chronic functional diarrhoea, and chronic constipation, according to the Roma III criteria. Among organic conditions associated with NLH, the most frequent was IBD, followed by infections and diverticular disease. IBS: Irritable bowel syndrome; IBD: Inflammatory bowel disease.